On August 17, 2020, LAW360 reported that "China has granted CanSino Biologics Inc. and a military scientist the first patent for a COVID-19 vaccine candidate, state media reported Sunday."
Apparently, claim
1 of the patent that was granted is directed to the spike protein (S protein)
of COVID-19:
Issued claim: A polynucleotide encoding S protein of 2019 novel coronavirus, characterized in that the sequence of the polynucleotide is shown in SEQ ID NO:1.
The spike protein (S protein) mediates the attachment between the virus and the host cell surface receptors.
If you need additional information on the granted Chinese
patent, please contact this law firm in China: czipa@czipa.com.
